| 摘要 |
<p>Compound of formula (I) and salts thereof are provided: wherein A, R<SUP>1</SUP>, R, R<SUP>2</SUP> are as defined in the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.</p> |
| 申请人 |
GLAXO GROUP LIMITED;BERTHELEME, NICOLAS;BRADLEY, DANIEL, MARCUS;CARDULLO, FRANCESCA;MERLO, GIANCARLO;POZZAN, ALFONSO;SCOTT, JAQUELINE, SANDRA;THEWLIS, KEVIN, MICHAEL;WARD, SIMON, EDWARD |
发明人 |
BERTHELEME, NICOLAS;BRADLEY, DANIEL, MARCUS;CARDULLO, FRANCESCA;MERLO, GIANCARLO;POZZAN, ALFONSO;SCOTT, JAQUELINE, SANDRA;THEWLIS, KEVIN, MICHAEL;WARD, SIMON, EDWARD |
